Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024
February 19, 2024
Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024
Dr. Polina Dombure, MD, CEO of Inpharmatis Group and a member of the TOPRA, engaged in the TOPRA Summit held on February 15, 2024, in London.
Dr. Dombure exchanged opinions with industry leaders and discussed key success factors essential for shaping the future of a safe regulatory system.
During the TOPRA Summit, dr. Dombure had the opportunity to meet with current and potential partners to discuss the industry’s challenges, as well as collaboration opportunities.
As a leading international consulting company in regulatory affairs, Inpharmatis Group continues to expand collaborations and strengthen its position in the pharmaceutical market.
For more information about Inpharmatis Group and its provided services, please contact us at info@inpharmatis.com.
Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024
Join us at RAPS Euro Convergence 2024 on 6-8 May in Berlin, Germany
April 26, 2024
Полина Домбуре, директор Inpharmatis, приняла участие в ISPE Europe Annual Conference 2024
April 23, 2024
Dr. Polina Dombure, Inpharmatis Group CEO, Participated in ISPE Europe Annual Conference 2024
April 23, 2024
Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024
Challenges of Medical Devices Registration in the EAEU
March 26, 2024
Новые поправки к Федеральному закону "Об обращении лекарственных средств" в России
March 13, 2024
New Amendments in Federal Law “On Circulation of Medicines” in Russia
March 13, 2024
В Грузии фармацевтические компании, не предоставившие сертификат GMP, столкнулись с новыми рисками
February 28, 2024